Loading…
Argentum Medical was awarded a five-year contract worth up to $14.7 million with the U.S. Department of Defense Electronic Catalog System for 62 Silverlon antimicrobial dressing products.
Argentum Medical acquired worldwide exclusive licensing rights from Noble Biomaterials to manufacture silver-plated nylon fabrics for advanced wound care. The deal was inked July 12, 2019. Argentum Medical expects to assume manufacturing by February 2021.
Argentum Medical, LLC, an advanced wound care platform of Shore Capital Partners, acquired the TheraBond family of products from Alliqua BioMedical, Inc. The products include contact dressings, island dressings and wraps for burn care and wound care.